Skip to main content
Open Forum Infectious Diseases logoLink to Open Forum Infectious Diseases
. 2021 Aug 31;8(9):ofab455. doi: 10.1093/ofid/ofab455

Meningovascular Syphilis Presenting as a Brain Mass in an Immunocompetent Male

Khanh Pham 1,, Lee Gottesdiener 1, Matthew S Simon 1,2, Alex Trzebucki 1, Grace A Maldarelli 1, Babacar Cisse 1,3, Joshua Lieberman 4, Elliot DeHaan 1,2, David Pisapia 1,5
PMCID: PMC8454516  PMID: 34557566

Abstract

We present a case of a human immunodeficiency virus–negative man with syphilitic meningovascular disease with subjacent involvement of brain parenchyma leading to a mass-forming inflammatory lesion that was pathologically distinct from a typical gumma. Syphilis was diagnosed after tissue obtained from a brain biopsy demonstrated spirochetes consistent with Treponema pallidum and confirmed by 16S ribosomal RNA sequencing.

Keywords: incipient gumma, meningovascular syphilis, PCR


The mass-forming granulomatous and necrotic lesions known as syphilitic gummas are typically a manifestation of tertiary syphilis [1]. Gummas commonly manifest as cutaneous lesions but can form in various organs including the brain. Acute manifestations of neurosyphilis include meningovascular disease and obliterative endarteritis of central nervous system (CNS) vessels leading to stroke-like presentations, while late presentations manifest as brain and spinal cord parenchymatous disease, during which destruction of nerve cells leads to clinicopathological syndromes referred to as general paresis or tabes dorsalis [1].

In this case, we present a lesion in an immunocompetent man that we hypothesize represents syphilitic meningovascular disease that subsequently involved the subjacent brain parenchyma leading to a mass-forming inflammatory lesion and initially mimicking a malignancy. With malignancy ruled out, this lesion was found to be similar to incipient formation of a gumma, but ultimately exhibited distinct pathologic characteristics from a typical gumma.

CASE REPORT

A 25-year-old man who has sex with men, without significant medical history, was transferred to our hospital for further evaluation after his third episode of dizziness and syncope over a 2-week period that was associated with abnormal CNS imaging. Prior to his first episode of syncope, he reported a frontal headache lasting 2 days that self-resolved. Each episode of dizziness was described as a loss of depth perception and proprioception culminating in syncope. After regaining consciousness, the patient reported an immediate return to baseline mental status. He denied concomitant fevers, chills, cough, dyspnea, abdominal pain, nausea, vomiting, or diarrhea.

Of note, he reported a small slowly healing neck ulceration that he attributed to an insect bite sustained during a hike in upstate New York approximately 3 months prior to his first episode of syncope. At the time of the ulcer, he was seen by his internist and received 2 weeks of empiric treatment with oral doxycycline and clindamycin with subsequent resolution of the ulcer. He additionally reported a history of unprotected sexual activity with a new male partner 3 months prior to the onset of syncope and received a sexually transmitted illness screen subsequently at a local clinic. The screening tests only included a point-of-care human immunodeficiency virus (HIV) test and urine gonorrhea and chlamydia nucleic acid amplification tests, which were negative. He was unaware of previous syphilis screening; however, collateral information from the New York City Department of Health and Mental Hygiene revealed that the patient had prior negative treponemal and nontreponemal syphilis tests 2 years prior to this presentation.

On arrival to our hospital, the patient’s vital signs were normal: temperature of 36.6°C (97.9°F), blood pressure of 116/71 mm Hg, pulse rate of 61 beats per minute, respiration rate of 16 breaths per minute, and an oxygen saturation of 98% on room air. On physical examination, he was well-appearing and in no acute distress. Neurologic examination at presentation was intact. There was also a demarcated, hypopigmented patch of approximately 2 × 2 cm on his right neck that was nontender. His genital examination was normal. There were no lymphadenopathy or other skin lesions.

Initial investigative studies included a complete blood count, basic metabolic panel, and liver function tests, all of which were within normal limits. Magnetic resonance imaging (MRI) of the brain revealed a well-circumscribed, cortically based mass measuring 4.0 × 3.1 × 2.5 cm within the right posterior temporo-occipital lobe that was centrally and heterogeneously T2 hyperintense and T1 hypointense (Figure 1). When compared to another MRI done at an outside hospital within the prior week, it appeared that the mass had increased in size, concerning for a neoplasm.

Figure 1.

Figure 1.

Preoperative brain magnetic resonance imaging. Preoperative axial T1 sequence with contrast. Abbreviations: AXL, axial; AFL, anterior/foot/left; FLAIR +C, fluid-attenuated inversion recovery with contrast; LH, left/head; PHR, posterior/head/right; RF, right/foot.

Given this concern for malignancy, the patient underwent a right craniotomy to remove the mass. Pathology from the excised tissue demonstrated a highly cellular, atypical, mixed lymphoplasmacytic infiltrate involving the leptomeninges and leptomeningeal vasculature with extension into the neocortical brain parenchyma and without prominent necrosis or prominent granuloma formation (Figure 2A–C). Immunohistochemical staining demonstrated many spirochetes, consistent with Treponema pallidum (Figure 2D).

Figure 2.

Figure 2.

Pathology of tissue obtained from craniotomy. A, Hematoxylin and eosin staining demonstrates a mixed lymphoplasmacytic infiltrate involving the leptomeninges and Virchow-Robin spaces. Scale bar: 100 μm. B, Diffuse parenchymal involvement and effacement of the underlying cerebral cortical architecture. Scale bar: 50 μm. C, Immunohistochemical staining for CD138 highlights the extensive plasma cell involvement typical of syphilitic inflammatory lesions. Scale bar: 100 μm. D, Immunohistochemical staining against treponemal antigen shows numerous corkscrew-shaped organisms. Scale bar: 20 μm.

A serum rapid plasma reagin (RPR) test sent after surgery was positive with a titer of 1:4, which was confirmed with a positive T pallidum particle agglutination test. A fourth-generation HIV antigen/antibody test was negative. Blood cultures demonstrated no growth after 5 days. Cerebrospinal fluid (CSF) from a lumbar puncture was notably unremarkable with a CSF white blood cell count of 0–1 total nucleated cells/µL, glucose of 73 mg/dL, and protein of 23 mg/dL. The CSF BioFire Film Array multiplex polymerase chain reaction (PCR) assay, which does not detect T pallidum, was negative for meningoencephalitic pathogens. CSF cultures did not demonstrate growth. The CSF Venereal Disease Research Laboratory (VDRL) and fluorescent treponemal antibody absorption (FTA-ABS) tests were also negative.

To support the findings on immunohistochemical staining, formalin-fixed, paraffin-embedded tissue was sent to the University of Washington for broad-range bacterial PCR (16S ribosomal RNA [rRNA] gene amplification followed by Sanger sequencing), which detected T pallidum DNA and confirmed the pathologic findings.

The patient was diagnosed with syphilitic meningovascular disease that was thought to be early to late neurosyphilis occurring in the secondary stage of infection. He was treated with intravenous penicillin G at a dose of 24 million units daily for 14 days, followed by an additional dose of intramuscular benzathine penicillin G of 2.4 million units. He experienced complete resolution of his presenting symptoms. At 1- and 2-month outpatient follow-up visits, he reported no recurrence of symptoms. A 6-month follow-up MRI showed resolution of the mass lesion (Figure 3).

Figure 3.

Figure 3.

Postoperative brain magnetic resonance imaging. Postoperative (6-month follow-up) axial T1 sequence with contrast. Abbreviations: Ax, axial; AFR, anterior/foot/right; LHA, left/head/anterior; PHL, posterior/head/left; RFP, right/foot/posterior; TSE, turbo spin echo.

DISCUSSION

It should be noted that classic examples of gummas differ from the case here in that gummas are typically characterized by a large necrotic core rimmed with multinucleated cells and generally do not demonstrate a high spirochete density [2]. Histological assessment of our patient’s brain tissue did not demonstrate these features, leading us to conclude that the patient’s brain mass was not a gumma, but rather a mass-forming lesion that was similar to a gumma or incipient formation of one. Given his young age and previous negative syphilis tests 2 years prior to presentation, tertiary syphilis was also unlikely. His initial neck ulceration may have represented a primary syphilis chancre, secondary syphilis rash, or other process. With antitreponemal activity, the empiric doxycycline course given prior to his presentation would have provided some treatment for early syphilis manifestations and may have affected his RPR titer, but would have likely been inadequate for neurosyphilis, if present at the time.

Since the advent of penicillin treatment of syphilis in the early 1940s [3], syphilitic mass-forming lesions, such as cerebral gummas, have become increasingly rare [2], with Fargen and colleagues reporting 156 individual cases in 111 publications in a 2009 literature review. Due to the scarcity of cases and provider inexperience with this entity, the spectrum of CNS involvement by syphilitic lesions may pose a diagnostic challenge for physicians; syphilitic mass-forming lesions on radiographic imaging can mimic malignant primary or metastatic tumors [2, 4–20]. Of the 25 rare cases of cerebral gummas or syphilitic mass-forming lesions to be reported in the last 10 years to our knowledge, ours is the first to report confirmation of syphilitic meningovascular disease that is associated with a mass-forming lesion through a combination of positive serum tests, pathologic findings, and 16S rRNA sequencing for T pallidum (Table 1) [4–26]. While 24% of cases in the literature did not report CSF syphilis testing, the majority utilized traditional treponemal or nontreponemal testing, or a modified version of these tests such as the toluidine red unheated serum test [15, 26]. PCR testing was used rarely, in <10% of cases, and ours was the only case to use 16S rRNA sequencing.

Table 1.

Literature Review of Reported Cerebral Syphilitic Masses in the Last 10 Years With Pertinent Features of Demographics and Diagnostics Reported

First Author Year Age/Sex Country Known HIV Status CSF Treponemal Test CSF Nontreponemal Test PCR Test Surgery or Biopsy
Ventura [4] 2012 26/M Brazil Yes NR NR NR No
Dhasmana [8] 2013 40/M UK No Pos (TPPA) Pos (VDRL) NR Yes
Yoon [9] 2013 59/F South Korea No Pos (FTA-ABS) Neg (VDRL) Neg Yes
Sprenger [6] 2014 40/M Switzerland Yes Neg (TPHA) NR NR Yes
Hamauchi [22] 2014 23/F Japan No Pos (TPHA) NR NR No
Faropoulos [10] 2016 53/M Greece No NR NR NR Yes
Tsuboi [21] 2016 21/M Japan Yes Pos (FTA-ABS) Pos (TPHA) Neg (RPR) NR No
Zhang [11] 2017 56/M China No Pos (TPPA) Neg (RPR) Pos (polA) Yes
Xia [13] 2017 62/M China No Pos (TPPA) Pos (RPR) NR Yes
Murakawa [23] 2017 24/M Japan No Pos (TPPA) Pos (RPR) NR No
Shi [24] 2017 41/M China No NR Neg (RPR, VDRL) NR No
Kuroi [19] 2018 62/M Japan No NR Pos (RPR) NR Yes
Shao [7] 2018 62/M China No Pos (TPPA) Neg (RPR) NR Yes
Shao [7] 2018 66/M China No Pos (TPPA) Pos (RPR) NR Yes
Shao [7] 2018 37/M China No Pos (TPPA) Pos (RPR) NR No
Ying [18] 2018 52/F China No Pos (TPPA) Pos (RPR) NR Yes
Koizumi [5] 2018 44/M Japan Yes Neg (TPLA) Neg (RPR) Pos (polA, TpN47) Yes
Kodama [25] 2018 36/M Japan No Pos (TPLA) Pos (RPR) NR No
Weng [15] 2019 45/M China No Pos (TPPA) Pos (TRUST) NR Yes
Sasaki [16] 2019 47/M Japan No Pos (FTA-ABS, TPHA) NR NR No
Shen [26] 2019 22/M China No NR Pos (TRUST) NR No
Cui [14] 2020 52/F China No NR NR NR Yes
Xia [12] 2020 49/F China No NR NR NR Yes
Thibodeau [17] 2021 37/F USA No NR NR NR Yes
Yu [20] 2021 54/M China No NR NR NR Yes
This report 2021 25/M USA No Neg (FTA-ABS) Neg (VDRL) Pos (16S rRNA) Yes

Abbreviations: CSF, cerebrospinal fluid; F, female; FTA-ABS, fluorescent treponemal antibody absorption; HIV, human immunodeficiency virus; M, male; Neg, negative; NR, not reported; PCR, polymerase chain reaction; poIA, gene coding for DNA polymerase I; Pos, positive; RPR, rapid plasma reagin; rRNA, ribosomal RNA; TPHA, Treponema pallidum hemagglutination assay; TPLA, Treponema pallidum latex agglutination; TpN47, recombinant protein; TPPA, Treponema pallidum particle agglutination; TRUST, toluidine red unheated serum test; UK, United Kingdom; USA, United States; VDRL, Venereal Disease Research Laboratory.

Our case was also unusual as historically, case reports of syphilis that were complicated by mass-forming lesions typically involved patients who were HIV positive [4–6, 21]; our patient did not have HIV or any other known immunodeficiency. In the clinical setting, physicians may also be more likely to suspect a mass-forming lesion to be a consequence of syphilis in HIV-infected individuals rather than those without HIV. Interestingly, however, of the recent cases reviewed, only 16% involved patients who were found to be HIV positive, perhaps underscoring why this diagnosis is still often initially overlooked in HIV-negative individuals. Almost two-thirds of patients underwent either surgery or a biopsy to conclusively make the diagnosis of neurosyphilis.

Our case underscores the challenge of diagnosing syphilitic involvement of the CNS compartment, particularly when presenting as a mass-forming lesion similar to a gumma. Successful diagnosis of this entity often relies on serologic and CSF studies, as well as radiographic findings and pathologic analysis of body tissue. As noted in our patient, however, the CSF VDRL and FTA-ABS can be negative in syphilitic manifestations with CNS mass or gumma formation in 38%–40% of cases [2]. Negative CSF syphilis tests have also been reported in other cases [5, 6, 24]. Acute neurosyphilis typically presents clinically as symptomatic meningitis, with more CSF findings such as pleocytosis, elevated protein, decreased glucose, and positive VDRL, whereas cases of late neurosyphilis may not have these CSF findings [1–3]. Given meningovascular disease seen on pathology and an unremarkable CSF profile, our patient’s disease process may have been transitioning from early to late neurosyphilis. Diagnosis, therefore, often requires a high index of suspicion, and is based on clinical presentation and the deployment of laboratory testing for syphilis. More rarely, surgical biopsy may be warranted.

Syphilis cases, including those with neurologic involvement and congenital syphilis, have increased in New York City [27], across the United States [28], and globally [5]. Given the increasing incidence of this clinical entity, we suggest clinicians maintain a high index of suspicion for the atypical manifestations of syphilis and utilize laboratory testing liberally in an effort to prevent more invasive diagnostic modalities such as surgical biopsy. Public health messaging for syphilis prevention should also include examples of severe manifestations, as illustrated in this case. Through imaging findings that mimic malignancy, syphilitic mass-forming lesions may pose a diagnostic challenge and demonstrate yet another way in which syphilis proves to be the “great imitator.”

Notes

Patient consent statement. Written consent was obtained from the patient. This case conforms to the standards currently applied within the Division of Infectious Diseases at Weill Cornell Medicine.

Financial support. This study received support from New York–Presbyterian Hospital and Weill Cornell Medical College, including the Clinical and Translational Science Center (cooperative agreement UL1 TR000457) and Joint Clinical Trials Office, as well as the Weill Cornell T32 training grant (T32AI007613 Research Training in Infectious Diseases).

Potential conflicts of interest. All authors: No reported conflicts of interest.

All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

  • 1. Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999; 12:187–209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Fargen KM, Alvernia JE, Lin CS, Melgar M. Cerebral syphilitic gummata: a case presentation and analysis of 156 reported cases. Neurosurgery 2009; 64:568–75; discussion 575–6. [DOI] [PubMed] [Google Scholar]
  • 3. Mahoney JF, Arnold RC, Harris A. Penicillin treatment of early syphilis—a preliminary report. Am J Public Health Nations Health 1943; 33:1387–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Ventura N, Cannelas R, Bizzo B, Gasparetto EL. Intracranial syphilitic gumma mimicking a brain stem glioma. AJNR Am J Neuroradiol 2012; 33:E110–1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Koizumi Y, Watabe T, Ota Y, et al. Cerebral syphilitic gumma can arise within months of reinfection: a case of histologically proven treponema pallidum strain type 14b/f infection with human immunodeficiency virus positivity. Sex Transm Dis 2018; 45:e1–4. [DOI] [PubMed] [Google Scholar]
  • 6. Sprenger K, Furrer H. Chameleons everywhere. BMJ Case Rep 2014; 2014:bcr2014205608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Shao X, Qiang D, Liu Y, et al. Diagnosis and treatment of cerebral syphilitic gumma: a report of three cases. Front Neurosci 2018; 12:100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Dhasmana D, Joshi J, Manavi K. Intracerebral and spinal cord syphilitic gummata in an HIV-negative man: a case report. Sex Transm Dis 2013; 40: 629–31. [DOI] [PubMed] [Google Scholar]
  • 9. Yoon YK, Kim MJ, Chae YS, Kang SH. Cerebral syphilitic gumma mimicking a brain tumor in the relapse of secondary syphilis in a human immunodeficiency virus–negative patient. J Korean Neurosurg Soc 2013; 53:197–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Faropoulos K, Zolota V, Gatzounis G. Occipital lobe gumma: a case report and review of the literature. Acta Neurochir (Wien) 2017; 159: 199–203. [DOI] [PubMed] [Google Scholar]
  • 11. Zhang L, Zhou Y, Chen J, et al. A case of a cerebral syphilitic gumma developed in a few months mimicking a brain tumor in a human immunodeficiency virus–negative patient. Br J Neurosurg 2017; 31:481–3. [DOI] [PubMed] [Google Scholar]
  • 12. Xia K, Guo Z, Xia X, et al. Multi-syphilitic gummas in pituitary and cerebellopontine angle in a patient. Pituitary 2020; 23:253–7. [DOI] [PubMed] [Google Scholar]
  • 13. Xia DY, Zhu MF, Liu CG, et al. Cerebral syphilitic gumma misdiagnosed as a malignant brain tumor. J Craniofac Surg 2017; 28:e170–2. [DOI] [PubMed] [Google Scholar]
  • 14. Cui L, Liu J, Zhang W, et al. The application of MR spectroscopy and MR perfusion in cerebral syphilitic gumma: a case report. Front Neurosci 2020; 14:544802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Weng C, Huang K, Jiang T, et al. Cerebral syphilitic gumma masquerading as cerebral metastatic tumors: case report. Neurosurg Focus 2019; 47:E15. [DOI] [PubMed] [Google Scholar]
  • 16. Sasaki R, Tanaka N, Okazaki T, Yonezawa T. Multiple cerebral syphilitic gummas mimicking brain tumor in a non-HIV-infected patient: a case report. J Infect Chemother 2019; 25:208–11. [DOI] [PubMed] [Google Scholar]
  • 17. Thibodeau R, Goel A, Jafroodifar A, et al. Cerebral syphilitic gumma presenting with intracranial gumma and pathologic vertebrae fractures. Radiol Case Rep 2021; 16:916–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Ying S, Li-Min L. Cerebral syphilis mimicking metastatic tumors: report and review of the literature. Neurol India 2018; 66:1170–2. [DOI] [PubMed] [Google Scholar]
  • 19. Kuroi Y, Tani S, Shibuya M, Kasuya H. Teaching neuroimages: cerebral syphilitic gumma with numerous spirochetes in immunohistochemical staining. Neurology 2018; 90:e818–9. [DOI] [PubMed] [Google Scholar]
  • 20. Yu Q, Li W, Mo X, et al. Case report: microglia composition and immune response in an immunocompetent patient with an intracranial syphilitic gumma. Front Neurol 2020; 11:615434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Tsuboi M, Nishijima T, Teruya K, et al. Cerebral syphilitic gumma within 5 months of syphilis in HIV-infected patient. Emerg Infect Dis 2016; 22:1846–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Hamauchi A, Abe T, Nihira A, et al. A case of cerebral syphilitic gumma mimicking a brain tumor [in Japanese]. Rinsho Shinkeigaku 2014; 54:738–42. [DOI] [PubMed] [Google Scholar]
  • 23. Murakawa M, Shibuya K, Sekiguchi Y, Kuwabara S. Pontine syphilitic gumma in an HIV-negative patient. Intern Med 2017; 56:1747–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Shi F, Jiang H, Shi Z, et al. Cerebral syphilitic gumma: case report of a brainstem mass lesion and brief review of the literature. Jpn J Infect Dis 2017; 70:595–6. [DOI] [PubMed] [Google Scholar]
  • 25. Kodama T, Sato H, Osa M, et al. Cerebral syphilitic gumma in immunocompetent man, Japan. Emerg Infect Dis 2018; 24:395–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Shen S, Yang R, Wang L, et al. Multiple intracranial and spinal cord syphilitic gummas in a human immunodeficiency virus–negative man with untreated syphilis: a case report. Medicine (Baltimore) 2019; 98:e16887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Schillinger JA, Slutsker JS, Pathela P, et al. The epidemiology of syphilis in New York City: historic trends and the current outbreak among men who have sex with men, 2016. Sex Transm Dis 2018; 45:48–54. [DOI] [PubMed] [Google Scholar]
  • 28. Kimball A, Torrone E, Miele K, et al. Missed opportunities for prevention of congenital syphilis—United States, 2018. MMWR Morb Mortal Wkly Rep 2020; 69:661–5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Open Forum Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES